AI in Clinical Trials Market Set to Reach Multi-Billion Dollar Valuation by 2031 as Deep Learning Redefines Drug R&D Pipelines, Reports BMAG Consulting
FLORIDA, United States, July 5, 2026 — FOR IMMEDIATE RELEASE
The global life sciences sector is experiencing an unprecedented technological revolution as artificial intelligence transitions from an experimental tool to the backbone of...
Cell and Gene Therapy Clinical Trials Market to Expand at a CAGR of 15.7% Through 2036, Driven by Expanding Institutional Adoption and Advanced Therapy Infrastructure
Rockville, Maryland, USA— According to Fact.MR The global cell and gene therapy clinical trials market is witnessing robust growth momentum as advanced therapy development accelerates worldwide. According to recent...
NEWARK, DE | February 5, 2026 — The global clinical research ecosystem is entering a new era of scale and complexity. As pharmaceutical, biotechnology, and medical device companies accelerate innovation across oncology, rare diseases, and advanced biologics, the Clinical Trials Market—valued at USD 131.8 billion in 2026—is projected to reach USD 200.9 billion by...
The pharmaceutical industry has long been known for its tradition, meticulousness, and let’s be honest a fair bit of slow-moving bureaucracy. For decades, clinical trials followed a rigid "brick-and-mortar" site model. Patients traveled hours to hospitals, sat in waiting rooms, and filled out endless stacks of paper. It was a system that worked, but it wasn't exactly efficient or...
Decentralized Clinical Trials Market Set to Reach $19.6 Billion by 2032, Fuelled by Digital Health Innovation and Patient-Centric Designs, Reports BMAG Consulting
FLORIDA, United States, July 5, 2026 — FOR IMMEDIATE RELEASE
The global pharmaceutical and biotechnology sectors are undergoing a massive paradigm shift, with the Decentralized Clinical Trials (DCT) Market emerging as the...
The U.S. cell and gene therapy market is witnessing unprecedented growth, fueled by rapid advancements in biotechnology, increasing research funding, and rising demand for personalized medicine. As healthcare systems shift toward targeted and curative treatments, the development and commercialization of advanced therapies are becoming central to the industry’s evolution. The expanding...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek